Health Trials

About this trial

Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV).

Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators.

This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.

Eligibility criteria

Qualifiers

Patients aged between 1 and 8 years

Patients with ASA physical status I-II

Patients scheduled for elective orchiopexy

Obtained written informed consent from parents/guardians

Disqualifiers

Patients younger than 1 year or older than 8 years

Patients with ASA physical status III or higher

Presence of acute infection signs

History of previous nausea or vomiting

Trial design

Treatments tested in this trial

  • Measurement of Preoperative Inflammatory Biomarkers

Treatment groups

No treatment groups listed

Locations

1
Ankara Etlik City Hospital AltındağAnkara, Turkey (Türkiye)

Sponsors and collaborators

Diskapi Yildirim Beyazit Education and Research Hospital

Lead sponsor

Ankara Etlik City Hospital

Sponsor institution

Source ClinicalTrials.gov